Skip to main content

Clene Inc.

CLNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001822791

No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Clene Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of CLNN: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders4644−2
Shares11.6M7.29M−4.34M (−37.3%)
Value$3.50M$3.10M−$395.5K (−11.3%)

New holders (7)

Institutions that held Clene Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to CLNN in Q1 2024
InstitutionSharesValue% of portfolio
EP Wealth Advisors, LLC44,984$19.1K0.00%
HRT Financial LP33,018$14.0K0.00%
Two Sigma Securities, LLC31,495$13.4K0.00%
XTX Topco Ltd25,047$10.7K0.00%
Lincoln National Corp20,350$8.66K0.00%
Renaissance Technologies LLC19,424$8.00K0.00%
Vontobel Holding Ltd.15,000$6.38K0.00%

Sold out (9)

Institutions that held Clene Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of CLNN in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
AWM Investment Company, Inc.2,691,213$798.2K
AE Wealth Management LLC172,528$91.1K
CVI Holdings, LLC111,200$33.0K
Soltis Investment Advisors LLC109,517$32.5K
Commonwealth Equity Services, LLC63,168$19.0K
Jane Street Group, LLC22,440$6.66K
ADAR1 Capital Management, LLC11,500$3.41K
Harbour Investments, Inc.275$82
FMR LLC1$0